Participant flow

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas · Source last updated 2026-01-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG000

   title

   Dose Regimen A (DR-A) Escalation (0.16 mg/kg)

2. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG001

   title

   Dose Regimen A (DR-A) Escalation (0.32 mg/kg)

3. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG002

   title

   Dose Regimen A (DR-A) Escalation (0.64 mg/kg)

4. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG003

   title

   Dose Regimen A (DR-A) Escalation (1.25 mg/kg)

5. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG004

   title

   Dose Regimen A (DR-A) Escalation (2.10 mg/kg)

6. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG005

   title

   Dose Regiment A (DR-A) Escalation (3.10 mg/kg)

7. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG006

   title

   Dose Regimen A (DR-A) Escalation (4.40 mg/kg)

8. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 4, 8 and 11 of a 21-day cycle ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG007

   title

   Dose Regimen B (DR-B) Escalation (0.32 mg/kg)

9. description

   Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

   id

   FG008

   title

   Dose Regimen B (DR-B) Escalation (0.53 mg/kg)

10. description

    Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

    id

    FG009

    title

    Dose Regimen B (DR-B) Escalation (0.80 mg/kg)

11. description

    Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

    id

    FG010

    title

    Dose Regimen B (DR-B) Escalation (1.10 mg/kg)

12. description

    Drug: ALRN-6924 Weight-based-dosing administered IV on days 1, 8 and 15 of a 28-day cycle. ALRN-6924: ALRN-6924 will be administered as an IV infusion

    id

    FG011

    title

    Dose Regimen B (DR-B) Escalation (1.50 mg/kg)

Show more (12 of 17)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         3

      3. group Id

         FG002

         num Subjects

         4

      4. group Id

         FG003

         num Subjects

         3

      5. group Id

         FG004

         num Subjects

         6

      6. group Id

         FG005

         num Subjects

         9

      7. group Id

         FG006

         num Subjects

         11

      8. group Id

         FG007

         num Subjects

         3

      9. group Id

         FG008

         num Subjects

         5

      10. group Id

          FG009

          num Subjects

          3

      11. group Id

          FG010

          num Subjects

          4

      12. group Id

          FG011

          num Subjects

          4

      Show more (12 of 17)

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         1

      5. group Id

         FG004

         num Subjects

         1

      6. group Id

         FG005

         num Subjects

         0

      7. group Id

         FG006

         num Subjects

         1

      8. group Id

         FG007

         num Subjects

         0

      9. group Id

         FG008

         num Subjects

         0

      10. group Id

          FG009

          num Subjects

          0

      11. group Id

          FG010

          num Subjects

          0

      12. group Id

          FG011

          num Subjects

          0

      Show more (12 of 17)

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         3

      3. group Id

         FG002

         num Subjects

         4

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         5

      6. group Id

         FG005

         num Subjects

         9

      7. group Id

         FG006

         num Subjects

         10

      8. group Id

         FG007

         num Subjects

         3

      9. group Id

         FG008

         num Subjects

         5

      10. group Id

          FG009

          num Subjects

          3

      11. group Id

          FG010

          num Subjects

          4

      12. group Id

          FG011

          num Subjects

          4

      Show more (12 of 17)

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice